KALLIE BELFIELD: Open Payments
NPI 1285171462 · POTOSI, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 34 payments from 8 companies in 2025. Trend: 2023 $1,014 · 2024 $956 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $255 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $119 |
| HARMONY BIOSCIENCES LLC | 3 | $108 |
| Alkermes, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $30 |
| Braeburn Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: CAPLYTA, WAKIX, VRAYLAR, QULIPTA, UBRELVY, ARISTADA, NURTEC ODT, MOUNJARO.
Industry payments across MO — which companies pay providers there.
